CXCR3 and neoplasm: Interestingly, we found that dual doses of FAP-CAR T cells not only slowed growth of the tumors but initially induced a degree of tumor regression compared to tumors in mice that received a first dose of FAP-CAR T cells with a subsequent dose of MigR control T cells.